Get the Stockscreener App
17.19
0.41%
0.07
Abrdn Life Sciences Investors stock is traded at $17.19, with a volume of 106.22K.
It is up +0.41% in the last 24 hours and up +3.37% over the past month.
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mostly in securities of Life Sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser, abrdn Inc to have potential for above-average growth.
See More
Previous Close:
$17.12
Open:
$17
24h Volume:
106.22K
Relative Volume:
0.57
Market Cap:
$496.32M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-1.66%
1M Performance:
+3.37%
6M Performance:
+36.97%
1Y Performance:
+20.80%
1-Day Range:
$16.95
$17.26
1-Week Range:
$16.86
$17.70
52-Week Range:
$10.55
$17.80
Abrdn Life Sciences Investors Stock (HQL) Company Profile
Name
Abrdn Life Sciences Investors
Sector
Industry
Phone
-
Address
-
Compare HQL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HQL
Abrdn Life Sciences Investors
|
17.19 | 494.30M | 0 | 0 | 0 | 0.00 |
|
DNP
Dnp Select Income Fund Inc
|
10.11 | 3.76B | 0 | 0 | 0 | 0.00 |
|
UTG
Reaves Utility Income Fund
|
37.67 | 3.36B | 0 | 0 | 0 | 0.00 |
|
ADX
Adams Diversified Equity Fund
|
23.07 | 2.77B | 0 | 0 | 0 | 0.00 |
|
ETY
Eaton Vance Tax Managed Diversified Equity Income Fund
|
15.63 | 2.47B | 0 | 0 | 0 | 0.00 |
|
GDV
Gabelli Dividend Income Trust
|
27.26 | 2.42B | 0 | 0 | 0 | 0.00 |
Abrdn Life Sciences Investors Stock (HQL) Latest News
Will abrdn Life Sciences Investors Shares stock draw ESG focused funds2025 Market Outlook & Risk Managed Investment Signals - Newser
Why abrdn Life Sciences Investors Shares stock could be next leader2025 Year in Review & Fast Moving Stock Trade Plans - Newser
Why abrdn Life Sciences Investors Shares stock could rally stronglyEntry Point & Low Drawdown Trading Strategies - Newser
How abrdn Life Sciences Investors Shares stock moves on employment dataRate Hike & Consistent Income Trade Ideas - Newser
How abrdn Life Sciences Investors Shares stock stacks up against competitorsStop Loss & Weekly Top Stock Performers List - Newser
Can abrdn Life Sciences Investors Shares stock ride next bull market cyclePortfolio Growth Summary & Real-Time Buy Signal Alerts - Newser
Can abrdn Life Sciences Investors Shares stock sustain double digit ROE2025 Performance Recap & Real-Time Chart Breakout Alerts - Newser
Published on: 2025-11-30 09:09:10 - moha.gov.vn
How Abrdn Healthcare Investors stock reacts to inflationary pressuresPortfolio Risk Summary & Weekly Setup with High ROI Potential - BỘ NỘI VỤ
What Wall Street predicts for Abrdn Life Sciences Investors stock priceJuly 2025 Chart Watch & Detailed Earnings Play Alerts - moha.gov.vn
Advisors Asset Management Inc. Raises Stake in abrdn Healthcare Investors $HQH - MarketBeat
How buybacks impact Abrdn Healthcare Investors stock valueTrade Volume Report & Free Technical Pattern Based Buy Signals - BỘ NỘI VỤ
Is Abrdn Life Sciences Investors stock a top pick in earnings seasonPortfolio Performance Report & Safe Swing Trade Setup Alerts - BỘ NỘI VỤ
Is Abrdn Healthcare Investors stock vulnerable to regulatory risksJuly 2025 Volume & Risk Adjusted Buy and Sell Alerts - BỘ NỘI VỤ
Head to Head Contrast: Invesco QQQ (NASDAQ:QQQ) & abrdn Healthcare Investors (NYSE:HQH) - Defense World
Saba Capital Management, L.P. Reduces Stake in abrdn Life Sciences Investors - GuruFocus
AlphaCore Capital LLC Has $672,000 Stake in abrdn Healthcare Investors $HQH - MarketBeat
Amplify CEF High Income ETF Holdings - Quiver Quantitative
Cash from operating activities of abrdn Life Sciences Investors of Benef Interest – BOATS:HQL - TradingView
Abrdn Life Sciences Investors To Go Ex-Dividend On November 21st, 2025 With 0.5 USD Dividend Per Share - 富途牛牛
Why Abrdn Life Sciences Investors stock is a value investor pickJuly 2025 Price Swings & Advanced Technical Analysis Signals - newser.com
abrdn Healthcare Investors $HQH Stake Raised by Allworth Financial LP - Defense World
Is abrdn Life Sciences Investors Shares stock expanding market penetrationDay Trade & Technical Pattern Based Signals - newser.com
Abrdn Life Sciences Investors Q3 2025 Commentary (NYSE:HQL) - Seeking Alpha
Can Abrdn Life Sciences Investors stock withstand economic slowdownJuly 2025 WrapUp & AI Enhanced Trading Alerts - newser.com
How institutional buying supports Abrdn Life Sciences Investors stockMarket Activity Recap & Entry Point Confirmation Signals - newser.com
What institutional flow reveals about Abrdn Life Sciences InvestorsPortfolio Risk Summary & Fast Entry Momentum Alerts - newser.com
Key resistance and support levels for Abrdn Life Sciences Investors2025 Risk Factors & Weekly Hot Stock Watchlists - newser.com
Reversal indicators forming on Abrdn Healthcare Investors stockMarket Sentiment Review & Fast Gain Stock Trading Tips - newser.com
Custom strategy builders for tracking Abrdn Life Sciences InvestorsEarnings Miss & Consistent Profit Trading Strategies - newser.com
Is Abrdn Life Sciences Investors stock ready for a breakoutJuly 2025 Setups & Daily Volume Surge Trade Alerts - newser.com
Does Abrdn Life Sciences Investors show high probability of rebound - newser.com
Abrdn Life Sciences Investors Stock (HQL) Financials Data
There is no financial data for Abrdn Life Sciences Investors (HQL). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.48%
1.30%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):